Consistent with our in vivo findings, a poor prognosis and short overall survival rate were observed for patients with HCC and high expressions of FOXM1 and its downstream proteins, AURKA and BIRC5 (Figure 8A,B). Here, BIRC5 is linked to hepatocellular carcinoma.